2004
DOI: 10.1016/j.mam.2004.02.014
|View full text |Cite
|
Sign up to set email alerts
|

Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
97
0
2

Year Published

2004
2004
2019
2019

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 151 publications
(103 citation statements)
references
References 54 publications
4
97
0
2
Order By: Relevance
“…Treatment with the combination of mitochondrial nutrients, more significantly than with pioglitazone, normalised the activity of liver mitochondrial complexes in GK rats towards that in non-diabetic Wistar rats, suggesting that the mitochondrion is a possible target of these nutrients. That complexes I, III and IV all respond similarly is consistent with other characteristics they have in common: the activities of all three are inhibited by NO (34) , critical subunits of all three are encoded by mitochondrial genes (in contrast to complex II) and all three act to pump protons out of the mitochondrial matrix (in contrast to complex V). The increases in complexes II and V are consistent with a previous report by Ferreira et al (31) but the changes in complexes I and IV are different.…”
Section: Discussionsupporting
confidence: 81%
“…Treatment with the combination of mitochondrial nutrients, more significantly than with pioglitazone, normalised the activity of liver mitochondrial complexes in GK rats towards that in non-diabetic Wistar rats, suggesting that the mitochondrion is a possible target of these nutrients. That complexes I, III and IV all respond similarly is consistent with other characteristics they have in common: the activities of all three are inhibited by NO (34) , critical subunits of all three are encoded by mitochondrial genes (in contrast to complex II) and all three act to pump protons out of the mitochondrial matrix (in contrast to complex V). The increases in complexes II and V are consistent with a previous report by Ferreira et al (31) but the changes in complexes I and IV are different.…”
Section: Discussionsupporting
confidence: 81%
“…This special characteristic is frequently referred as complex I syndrome, with the symptoms of reduced mitochondrial respiration with malate-glutamate and ADP and of reduced complex I activity. This complex I syndrome has been observed in aging (Navarro et al, 2005;Navarro  Boveris, 2004, in ischemia-reperfusion (Gonzalez-Flecha et al, 1993), in Parkinson's disease, and in other neurodegenerative diseases (Schapira et al, 1990a(Schapira et al, , 1990bSayre et al, 1999;Carreras et al, 2004;Schapira, 2008;, and in this study, with the addition of the increased rates of production of O2 .-and H2O2 by complex I mediated reactions, reactions with the free radicals intermediates of the lipid peroxidation process (mainly ROO·), and amine-aldehyde adduction reactions. It is now understood that the three processes above mentioned alter the native non-covalent polypeptide interactions of complex I and promote synergistically protein damage and inactivation by shifting the noncovalent bonding to covalent cross linking (Navarro et al, 2005).…”
Section: Mitochondriamentioning
confidence: 99%
“…Therefore, the inhibition of GDC activity after GSNO treatment could have been an indirect effect of ROS induced by inhibition of complex I. It is well known that the activity of complex I of the mitochondrial electron transport chain is inhibited by nitrosothiols and peroxinitrite (Carreras et al, 2004;Dahm et al, 2006). This inhibition results in increased production of ROS, which can cause oxidative damage of GDC (Taylor et al, 2002).…”
Section: Inhibition Of Gly Decarboxylase Activity By Gsnomentioning
confidence: 99%